These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8690750)

  • 1. Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model.
    Van de Vrie W; Schellens JH; Loss WJ; Kolker HJ; Verwey J; Stoter G; Durante NM; Eggermont AM
    J Cancer Res Clin Oncol; 1996; 122(7):403-8. PubMed ID: 8690750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag/Rij rats.
    Schellens JH; Van de Vrie W; Loos WJ; Kolker HJ; Verweij J; Stoter G; Durante NM; Eggermont AM
    Cancer Chemother Pharmacol; 1997; 41(1):48-52. PubMed ID: 9443613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
    Van de Vrie W; Gheuens EE; Durante NM; De Bruijn EA; Marquet RL; Van Oosterom AT; Eggermont AM
    J Cancer Res Clin Oncol; 1993; 119(10):609-14. PubMed ID: 8101524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
    Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
    Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O
    Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.
    Kraus-Berthier L; Guilbaud N; Peglion JL; Leonce S; Lombet A; Pierre A; Atassi G
    Acta Oncol; 1994; 33(6):631-7. PubMed ID: 7946440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A enhances locoregional metastasis of the CC531 rat colon tumour.
    Van de Vrie W; Marquet RL; Eggermont AM
    J Cancer Res Clin Oncol; 1997; 123(1):21-4. PubMed ID: 8996536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by amitriptyline in vitro.
    Varga A; Nugel H; Baehr R; Marx U; Hevér A; Nacsa J; Ocsovszky I; Molnar J
    Anticancer Res; 1996; 16(1):209-11. PubMed ID: 8615610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetic characteristics of dexniguldipine-HCl, a new anticancer drug.
    Goedhals L; Bezwoda WR; Abratt RP; Rathgeb F; Goebel KJ; Wurst W
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):664-9. PubMed ID: 8963484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).
    Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP
    Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A.
    Ise W; Heuser M; Sanders K; Beck J; Gekeler V
    Int J Oncol; 1996 May; 8(5):951-6. PubMed ID: 21544450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial.
    Ukena D; Boewer C; Oldenkott B; Rathgeb F; Wurst W; Zech K; Sybrecht GW
    Cancer Chemother Pharmacol; 1995; 36(2):160-4. PubMed ID: 7767953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
    Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
    Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
    Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression.
    Murata T; Hatayama I; Kakizaki I; Satoh K; Sato K; Tsuchida S
    Jpn J Cancer Res; 1996 Nov; 87(11):1171-8. PubMed ID: 9045947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.